DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 94 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,771,248 | +31.1% | 551,854 | +27.6% | 0.00% | 0.0% |
| Q2 2023 | $5,165,148 | +76.0% | 432,592 | +97.1% | 0.00% | 0.0% |
| Q1 2023 | $2,934,996 | -39.5% | 219,521 | -2.6% | 0.00% | 0.0% |
| Q4 2022 | $4,847,790 | +7.6% | 225,269 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $4,507,000 | +32.2% | 225,050 | +18.1% | 0.00% | 0.0% |
| Q2 2022 | $3,410,000 | +101.9% | 190,510 | +11.9% | 0.00% | – |
| Q1 2022 | $1,689,000 | -3.3% | 170,299 | +64.3% | 0.00% | – |
| Q4 2021 | $1,747,000 | -25.0% | 103,677 | +5.7% | 0.00% | – |
| Q3 2021 | $2,328,000 | +702.8% | 98,099 | +671.3% | 0.00% | – |
| Q2 2021 | $290,000 | – | 12,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |